Abstract
Joint involvement is one of the most frequent clinical complications of acromegaly. The aim of this study was to evaluate the femoral cartilage thicknesses of acromegalic patients using ultrasound (US). Sixty-two patients diagnosed with acromegaly (30 F, 32 M) were included. Patients’ demographic and clinical characteristics were recorded. The thickness of the femoral articular cartilage was measured using a 6- to 18-MHz linear probe. Measurements were performed bilaterally from three points (medial condyle, intercondylar area, and lateral condyle). Of the patients, 14 (22.5 %) reported pain in the knee joints. A significantly higher femoral articular cartilage thickness was determined in the patients compared with the controls (all parameters, p < 0.001). US measurements results from all points were consistent, but these values were not correlated with levels of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Analysis of acromegaly patients as active (n = 37) or inactive (n = 25) revealed no significance with respect to femoral cartilage thickness. Acromegalic patients seem to have thicker femoral articular cartilages irrespective of disease activity state.
Similar content being viewed by others
References
Bauman G (2002) Growth hormone and its disorders. In: Becker KL, Kahn RC, Rebar RW (eds) Principles and practices of endocrinology and metabolism. Lippincott Williams & Wilkins, Philadelphia, pp 129–45
Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P (1998) Arthropathy in acromegalic patients before and after treatment: a long term follow up study. Clin Endocrinol 28:515–524
Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH (1988) Acromegalic arthropathy: characteristics and response to therapy. Arthritis Rheum 31:1022–1027
Podgorski M, Robinson B, Weissberger A, Steil J, Wang S, Brooks PM (1998) Articular manifestations of acromegaly. Aust NZ J Med 18:28–35
Lacks S, Jacobs RP (1986) Acromegalic arthropathy: a reversible rheumatic disease. J Rheumatol 13:634–636
Roelfsema F, van Dulken H, Frolich M (1985) Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol 23:555–565
Eryılmaz OG, Kara M, Tiftik T, Aksakal FN, Uzunlar Ö, Su FA et al (2012) Ultrasonographic measurement of the femoral cartilage thickness in patients with polycystic ovary syndrome. Fertil Sterility J 97(1):235–237
Kara M, Tiftik T, Öken Ö, Akkaya M, Tunc H, Özcakar L (2013) Ultrasonographic measurement of femoral cartilage thickness in patients with spinal cord injury. J Rehabil Med 45(2):145–148
Kaya A, Kara M, Tiftik T, Ozel S, Ersöz M, Göker M et al (2013) Ultrasonographic evaluation of the muscle architecture in patients with systemic lupus erythematosus. J Clin Rheumatol 32(8):1155–1160
Saarakkala S, Waris P, Waris V, Tarkiainen I, Karvanen E, Aarnio J, Koski JM (2012) Diagnostic performance of knee ultrasonography for detecting degenerative changes of articular cartilage. Osteoarthritis Cartilage 20(5):376–381
Naredo E, Acebes C, Möller I, Canillas F, de Agustin JJ, de Miguel E et al (2009) Ultrasound validity in the measurement of knee cartilage thickness. Ann Rheum Dis 68:1322–1327
Colao A, Marzullo P, Vallone G, Marino V, Annecchino M, Ferone D et al (1998) Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab 83:2121–2125
Colao A, Marzullo P, Vallone G, Giaccio A, Ferone D, Rossi E (1999) Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months. Clin Endocrinol 51:611–618
Möller I, Bong D, Naredo E, Filippuci E, Carrasco I, Moragues C (2008) Ultrasound in the study and monitoring of osteoarthritis. Osteoarthritis Cartilage 16:4–7
Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526–529
Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al (2010) Acromegaly Consensus Group: a consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148
Elmlinger MW, Kühnel W, Weber MM, Ranke MB (2004) Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med J 42(6):654–664
Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152
Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman LA, Gaillard R (2005) Consensus statement: medical management of acromegaly. Eur J Endocrinol 153:737–740
Lieberman SA, Bjorkengren AG, Hoffman AR (1992) Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am 21:615–631
Lee CL, Huang MH, Chai CY, Chen CH, Su JY, Tien YC (2008) The validity of in vivo ultrasonographic grading of osteoarthritic femoral condylar cartilage: a comparison with in vitro ultrasonographic and histologic gradings. Osteoarthritis Cartilage 16:352–358
Conflict of interest
There are no conflicts of interest to declare. None of the authors of this paper has a financial or personal relationship with other people or organizations that could inappropriately influence or bias the content of the paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
Karkucak M. and Batmaz I. equally contributed to this study.
Rights and permissions
About this article
Cite this article
Karkucak, M., Batmaz, İ., Civan, N. et al. Ultrasonographic measurement of femoral cartilage thickness in acromegalic patients. Clin Rheumatol 34, 157–161 (2015). https://doi.org/10.1007/s10067-014-2543-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2543-0